- Trials with a EudraCT protocol (43)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
43 result(s) found for: Birth trauma.
Displaying page 1 of 3.
EudraCT Number: 2016-002177-35 | Sponsor Protocol Number: GNB-2015 | Start Date*: 2018-05-07 |
Sponsor Name:Masarykova univerzita | ||
Full Title: The effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma | ||
Medical condition: Chronic neuropathic pain in patients after spinal cord trauma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002325-31 | Sponsor Protocol Number: 11.105 | Start Date*: 2005-11-04 |
Sponsor Name:Taunton & Somerset NHS Trust | ||
Full Title: Two parallel trials to compare the effectiveness, and potential adverse side-effects, of four routinely used topical therapies to prolong breastfeeding, by either (1) preventing or (2) treating nip... | ||
Medical condition: Nipple pain in breastfeeding women | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003382-38 | Sponsor Protocol Number: FSNANO05012022 | Start Date*: 2023-01-12 | |||||||||||
Sponsor Name:FSNANO05012022 | |||||||||||||
Full Title: Efficacy and safety of Cerebrolysin for neurorecovery after moderate-severe traumatic brain injury | |||||||||||||
Medical condition: Moderate-severe traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: RO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000446-30 | Sponsor Protocol Number: 02-2014 | Start Date*: 2014-07-23 |
Sponsor Name:Maasstad Ziekenhuis | ||
Full Title: Metformin vs Control to prevent gestational diabetes mellitus (GDM) in women with a high risk for GDM, an open label randomized controlled trial. The Medico-GDM trial. | ||
Medical condition: Pregnant women with a high risk of gestational diabetes mellitus (GDM) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001776-21 | Sponsor Protocol Number: NCT00687882 | Start Date*: 2016-03-10 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für | ||
Full Title: Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children | ||
Medical condition: Thrombosis in pediatric patients | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) NL (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2008-005892-83 | Sponsor Protocol Number: WCH/2008/001 | Start Date*: 2009-01-14 |
Sponsor Name:Epsom and St Helier University Hospitals NHS Trust | ||
Full Title: Does metformin improve pregnancy outcomes [ incidence of LGA (≥90% birth weight centile) babies onset of maternal Gestational Diabetes, hypertension, PET, shoulder dystocia, admission to SCBU) in o... | ||
Medical condition: Obesity in pregnancy. Obesity in pregnancy has been identified by Confidential Enquiry into Maternal And Child Health (CEMACH) (2008-2011) as a major health risk to mother and baby. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001718-13 | Sponsor Protocol Number: MP18 | Start Date*: 2019-10-18 |
Sponsor Name:MAPS Europe B.V. | ||
Full Title: An Open- Label, Phase 2, Multicenter Feasibility Study if Manualized MDMA-Assisted Psychotherapy with an fMRI sub-study Assessing Changes in Brain Activity in Subjects with Posttraumatic Stress Dis... | ||
Medical condition: post-traumatic stress disorder (PTSD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) CZ (Completed) NO (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-005093-40 | Sponsor Protocol Number: CS I-040202/01 | Start Date*: 2007-10-22 | |||||||||||
Sponsor Name:Kuros Biosurgery AG | |||||||||||||
Full Title: A phase II randomized, controlled, open-labeled (dose-blinded) dose finding study of the safety and efficacy of I-040202 in the treatment of patients with acute open tibial shaft fractures | |||||||||||||
Medical condition: Acute open tibial shaft fractures | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) HU (Completed) SI (Completed) FI (Completed) CZ (Completed) SK (Completed) IT (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000356-33 | Sponsor Protocol Number: oxy123 | Start Date*: 2013-03-27 | |||||||||||
Sponsor Name:Västra Götaland | |||||||||||||
Full Title: Delay in labour due to ineffective uterine contractions is still a major problem in modern obstetric care. It is one of the main reasons for the increased rate of operative deliveries, particularly... | |||||||||||||
Medical condition: Labor dystocia (LD) also referred to as prolonged labour is a commonly identified problem in modern delivery care with three described possible causes: inefficient uterine action, occiputposterior ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007110-29 | Sponsor Protocol Number: FGT1-0803 | Start Date*: 2009-02-17 | |||||||||||
Sponsor Name:LFB BIOTECHNOLOGIES | |||||||||||||
Full Title: An international randomised, double-blind, placebo-controlled study to assess the efficacy and safety of 2 dosing regimens of FIBRINOGENE T1 in the treatment of peri-operative bleeding associated w... | |||||||||||||
Medical condition: Severe Acute Haemorrhage (SAH) The main clinical situations of SAH are trauma and surgery-related haemorrhages and obstretical haemorrheges. Othopedic procedures can induce SAH. One of the most hae... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002148-15 | Sponsor Protocol Number: 201500214815 | Start Date*: 2017-06-01 |
Sponsor Name:Bethesda Diabetes research Center (BDRC) | ||
Full Title: Pregnancy Outcomes: Effects of Metformin Study (POEM Study) a long term randomized controlled parallel group study in gestational diabetes mellitus | ||
Medical condition: Gestational diabetes mellitus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000083-24 | Sponsor Protocol Number: GCPL/RGN/02 | Start Date*: 2007-06-07 | |||||||||||
Sponsor Name:Regen Therapeutics PLC | |||||||||||||
Full Title: A survey of efficacy of zolpidem in patients with brain injury including SPECT brain scans in selected patients | |||||||||||||
Medical condition: Brain damage of any original cause, such as strokes, trauma, birth injury, post-viral infection. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Not Authorised) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002880-82 | Sponsor Protocol Number: GUARD | Start Date*: 2020-05-05 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Randomised controlled trial of Gestational treatment with Ursodeoxycholic Acid compared to Metformin to Reduce effects of Diabetes mellitus | |||||||||||||
Medical condition: Gestational Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004255-36 | Sponsor Protocol Number: Cesar | Start Date*: 2020-10-05 |
Sponsor Name:Karolinska Universitetssjukhuset | ||
Full Title: Cesar - an open, randomized controlled phase II study, comparing Naltrexon and Fluoxetin treating Compulsive Sexual Behavior Disorder. | ||
Medical condition: Compulsive Sexual Behavior Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001478-14 | Sponsor Protocol Number: 071301 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Baxalta Innovations GmbH | ||||||||||||||||||
Full Title: A PROSPECTIVE, PHASE 3, OPEN LABEL, INTERNATIONAL MULTICENTER STUDY ON EFFICACY AND SAFETY OF PROPHYLAXIS WITH rVWF IN SEVERE VON WILLEBRAND DISEASE | ||||||||||||||||||
Medical condition: Hereditary severe von Willebrand Disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) IT (Completed) CZ (Completed) NL (Completed) ES (Completed) DE (Completed) FI (Completed) FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-004706-25 | Sponsor Protocol Number: V1290413 | Start Date*: 2014-04-02 |
Sponsor Name:University of Edinburgh (ACCORD) [...] | ||
Full Title: A Feasibility study looking at the use of Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS | ||
Medical condition: Gestational Diabetes Mellitus (GDM) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003586-41 | Sponsor Protocol Number: A6281289 | Start Date*: 2007-12-17 | |||||||||||
Sponsor Name:Pfizer Ltd. Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK | |||||||||||||
Full Title: Placebo-controlled trial on the efficacy of growth hormone replacement therapy in patients with growth hormone deficiency after traumatic brain injury | |||||||||||||
Medical condition: Growth hormone deficiency after traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) SE (Prematurely Ended) GB (Prematurely Ended) FR (Prematurely Ended) ES (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002301-23 | Sponsor Protocol Number: BAP00414 | Start Date*: 2005-12-14 | |||||||||||
Sponsor Name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole Medocaril Versus Vancomycin With Ceftazidime in The Treatment Of Complicated Skin And Skin Structure Infections | |||||||||||||
Medical condition: complicated skin and skin structure infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) LV (Completed) LT (Completed) EE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003473-17 | Sponsor Protocol Number: CC-90001-IPF-001 | Start Date*: 2017-09-14 | |||||||||||
Sponsor Name:Celgene Corporation | |||||||||||||
Full Title: A Phase 2, 24-Week Randomized, Double-blind, Placebo-Controlled Multicenter Study, With an 80-Week Active Treatment Extension, to Evaluate the Efficacy and Safety of CC-90001 in Subjects with Idiop... | |||||||||||||
Medical condition: IDIOPATHIC PULMONARY FIBROSIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001244-38 | Sponsor Protocol Number: 14SM1971 | Start Date*: 2014-07-16 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: Preventing Recurrent Gestational Diabetes Mellitus with Early Metformin Intervention | |||||||||||||
Medical condition: Gestational diabetes mellitus. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
